Impact of BMI on Survival Outcomes of Immunotherapy in Solid Tumors: A Systematic Review

Growing research has focused on obesity as a prognostic factor during therapy with immune-checkpoint inhibitors (ICIs). The role of body-mass index (BMI) in predicting response and toxicity to ICIs is not clear, as studies have shown inconsistent results and significant interpretation biases. We per...

Descripción completa

Detalles Bibliográficos
Autores principales: Indini, Alice, Rijavec, Erika, Ghidini, Michele, Tomasello, Gianluca, Cattaneo, Monica, Barbin, Francesca, Bareggi, Claudia, Galassi, Barbara, Gambini, Donatella, Grossi, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961496/
https://www.ncbi.nlm.nih.gov/pubmed/33807855
http://dx.doi.org/10.3390/ijms22052628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961496/
https://www.ncbi.nlm.nih.gov/pubmed/33807855
http://dx.doi.org/10.3390/ijms22052628

Ejemplares similares